相关实验视频

Updated: May 4, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

对于POLE突变子宫内膜癌治疗的安全降级治疗的关键考虑因素

Spencer D Martin¹, Jessica N McAlpine²

¹University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

|March 3, 2026

概括

患有POLE突变子宫内膜癌的患者有很好的结果. 放弃辅助治疗对于某些患者来说是安全的,正如PORTEC-4a试验所显示的那样,支持降级治疗策略.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
分子病理学分子病理学

背景情况:

波尔突变子宫内膜癌是一种独特的分子亚型,具有良好的临床结果.
致病性POLE突变导致DNA校对缺陷,导致超变异的表型和增强的抗瘤免疫力.
尽管其他亚型具有高风险特征,但POLE突变赋予了惰的过程.

研究的目的:

对精心挑选的POLE突变性子宫内膜癌患者进行支持降级治疗的证据进行审查.
突出临床实践中安全有效的治疗降级的关键因素.
基于前性试验数据,评估遗漏辅助治疗的安全性和有效性.

主要方法:

对回顾性研究,元分析和前性临床试验数据的分析,包括PORTEC-4a试验.
对POLE突变子宫内膜癌的诊断标准的评估,重点是验证的致病突变.
考虑与同时出现p53异常或不匹配修复缺陷的瘤的管理策略.

主要成果:

在PORTEC-4a试验证明了缓解升级辅助治疗的安全性,对于有利的POLE突变性子宫内膜癌 (I/II阶段) 的患者.
高度组织学,深度肌肉膜侵袭和淋巴血管侵袭不会对POLE突变瘤的结果产生负面影响.
使用11个经过验证的致病突变准确识别POLE突变对于治疗降级至关重要.

结论:

缓解辅助治疗对于精心挑选的患有POLE突变子宫内膜癌的患者来说是安全有效的.
严格的诊断标准和对共变的考虑对于安全实施降级治疗至关重要.
本综述为为POLE突变子宫内膜癌做出明智,安全的治疗决策提供了框架.

关键词:

临床试验临床试验宫内膜癌宫内膜癌是什么?多个分类器多个分类器波勒穆特 (Polemut) 是一个政治运动.在 PORTEC-4a 里面.致病性突变的病原性突变彩虹彩虹是一个彩虹.

更多相关视频

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

相关概念视频

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...